Is Avidity a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Avidity Biosciences Inc (RNA) is (126.01) USD. With the latest stock price at 31.11 USD, the upside of Avidity Biosciences Inc based on DCF is -505.1%. This means that Avidity is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.3% | 6.2% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (1,132.84) - (68.01) | (126.01) |
| Upside | -3741.4% - -318.6% | -505.1% |